-
I-Ruxolitinib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Ruxolitinib I-Myelofibrosis Novartis Julayi. 6, 2024 -
I-Crisaborole
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Crisaborole I-Atopic Dermatitis kanye ne-Eczema I-Pfizer Juni 11, 2026 -
I-Relugolix
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Relugolix Umdlavuza wendlala yesinye Takeda kanye ASKA Jan. 24, 2024 -
I-Vericiguat
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Vericiguat Ukuhluleka kwenhliziyo Bayer kanye ne-MSD Meyi.24, 2031 -
I-Abrocitinib
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Abrocitinib I-Atopic Dermatitis I-Pfizer Feb.11, 2034 -
I-Rimegepant
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Rimegepant Ikhanda le-Migraine I-Biohaven Februwari 22, 2031 -
Elagolix 834153-87-6
Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP ElagolixI-CAS:834153-87-6 I-Endometriosis Endlini -
Relugolix 737789-87-6
Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP I-Ribociclib CAS: 737789-87-6 I-Antineoplastic Endlini -
I-Venetoclax 1257044-40-8
Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US) I-Venetoclax 1257044-40-8 CLL Abbvie Jun.27,2031 -
I-Velpatasvir(PVP)
Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP I-Velpatasvir(PVP) I-HCV Endlini √ -
I-Thalidomide
Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP I-Thalidomide Umuthi we-Oncology USP/EP -
I-Ticagrelor
Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP I-Ticagrelor I-Anticoagulant Endlini 28984 √
